Trevi Therapeutics
TRVI
#7645
Rank
A$0.36 B
Marketcap
$4.99
Share price
5.71%
Change (1 day)
47.27%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$58.65 M

According to Trevi Therapeutics's latest financial reports the company's current earnings (TTM) are -A$58.16 M. In 2023 the company made an earning of -A$43.06 M a decrease over its 2022 earnings that were of -A$42.04 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$58.65 M36.21%
2023 -A$43.06 M2.43%
2022 -A$42.04 M-14.45%
2021 -A$49.14 M1.36%
2020 -A$48.48 M23.64%
2019 -A$39.21 M27.54%
2018 -A$30.75 M